Abstract
Traditional Chinese medicine (TCM) investigates the clinical diagnosis and treatment regularities in a typical schema of personalized medicine, which means that individualized patients with same diseases would obtain distinct diagnosis and optimal treatment from different TCM physicians. This principle has been recognized and adhered by TCM clinical practitioners for thousands of years. However, the underlying mechanisms of TCM personalized medicine are not fully investigated so far and remained unknown. This paper discusses framework of TCM personalized medicine in classic literatures and in real-world clinical settings, and investigates the underlying mechanisms of TCM personalized medicine from the perspectives of network medicine. Based on 246 well-designed outpatient records on insomnia, by evaluating the personal biases of manifestation observation and preferences of herb prescriptions, we noted significant similarities between each herb prescriptions and symptom similarities between each encounters. To investigate the underlying mechanisms of TCM personalized medicine, we constructed a clinical phenotype network (CPN), in which the clinical phenotype entities like symptoms and diagnoses are presented as nodes and the correlation between these entities as links. This CPN is used to investigate the promiscuous boundary of syndromes and the co-occurrence of symptoms. The small-world topological characteristics are noted in the CPN with high clustering structures, which provide insight on the rationality of TCM personalized diagnosis and treatment. The investigation on this network would help us to gain understanding on the underlying mechanism of TCM personalized medicine and would propose a new perspective for the refinement of the TCM individualized clinical skills.
Similar content being viewed by others
References
Piquette-Miller M, Grant DM. The art and science of personalized medicine. Clin Pharmacol Ther 2007; 81(3): 311–315
Lesko LJ. Personalized medicine: elusive dream or imminent reality? Clin Pharmacol Ther 2007; 81(6): 807–816
Hamburg MA, Collins FS. The path to personalized medicine. N Engl J Med 2010; 363(4): 301–304
Meyers DA, Bleecker ER, Holloway JW, Holgate ST. Asthma genetics and personalised medicine. Lancet Respir Med 2014; 2(5): 405–415
Mosli MH, Sandborn WJ, Kim RB, Khanna R, Al-Judaibi B, Feagan BG. Toward a personalized medicine approach to the management of inflammatory bowel disease. Am J Gastroenterol 2014; 109(7): 994–1004
Hutchinson L. Personalized cancer medicine: era of promise and progress. Nat Rev Clin Oncol 2011; 8(3): 121
Ginsburg GS, McCarthy JJ. Personalized medicine: revolutionizing drug discovery and patient care. Trends Biotechnol 2001; 19(12): 491–496
Pirmohamed M. Personalized pharmacogenomics: predicting efficacy and adverse drug reactions. Annu Rev Genomics Hum Genet 2014 May 29. [Epub ahead of print]
Weston AD, Hood L. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J Proteome Res 2004; 3(2): 179–196
Chung KF. Defining phenotypes in asthma: a step towards personalized medicine. Drugs 2014; 74(7): 719–728
Raciti GA, Nigro C, Longo M, Parrillo L, Miele C, Formisano P, Béguinot F. Personalized medicine and type 2 diabetes: lesson from epigenetics. Epigenomics 2014; 6(2): 229–238
Fraser M, Berlin A, Bristow RG, van der Kwast T. Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancer. Urol Oncol 2014 Apr 22. [Epub ahead of print] doi: 10.1016/j.urolonc.2013.10.020
Barabási AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet 2011; 12(1): 56–68
Committee on A Framework for Developing A New Taxonomy of Disease. Towards precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. Washington, DC: National Academies Press, 2011
Rzhetsky A, Wajngurt D, Park N, Zheng T. Probing genetic overlap among complex human phenotypes. Proc Natl Acad Sci USA 2007; 104(28): 11694–11699
Blair DR, Lyttle CS, Mortensen JM, Bearden CF, Jensen AB, Khiabanian H, Melamed R, Rabadan R, Bernstam EV, Brunak S, Jensen LJ, Nicolae D, Shah NH, Grossman RL, Cox NJ, White KP, Rzhetsky A. A nondegenerate code of deleterious variants in Mendelian loci contributes to complex disease risk. Cell 2013; 155(1): 70–80
Lee DS, Park J, Kay KA, Christakis NA, Oltvai ZN, Barabási AL. The implications of human metabolic network topology for disease comorbidity. Proc Natl Acad Sci USA 2008; 105(29): 9880–9885
van Driel MA, Bruggeman J, Vriend G, Brunner HG, Leunissen JA. A text-mining analysis of the human phenome. Eur J Hum Genet 2006; 14(5): 535–542
Zhou X, Menche J, Barabási AL, Sharma A. Human symptoms-disease network. Nat Commun 2014; 5: 4212
Vidal M, Cusick ME, Barabási AL. Interactome networks and human disease. Cell 2011; 144(6): 986–998
Anonymous. The Inner Canon of Emperor Huang, Beijing: Chinese Medical Ancient Books Publishing House, 2003
Jiang L, Liu B, Xie Q, Yang S, He L, Zhang R, Yan S, Zhou X, Liu J. Investigation into the influence of physician for treatment based on syndrome differentiation. Evid Based Complement Alternat Med 2013; 2013: 587234
Hu J, Liu B. The basic theory, diagnostic, and therapeutic system of traditional Chinese medicine and the challenges they bring to statistics. Stat Med 2012; 31(7): 602–605
Lu AP, Jia HW, Xiao C, Lu QP. Theory of traditional Chinese medicine and therapeutic method of diseases. World J Gastroenterol 2004; 10(13): 1854–1856
Xu H, Chen K. Integrative medicine: the experience from China. J Altern Complement Med 2008; 14(1): 3–7
Loscalzo J, Kohane I, Barabasi AL. Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol Syst Biol 2007; 3: 124
Liu B, Wang Y. Investigation on the concepts and their relationships among disease, symptoms and syndromes. J Tradit Chin Med 2007; 48: 293–298
Li Y, Zhou X, Zhang R, Wang Y, Peng Y, Hu J, Xie Q, Xue Y, Xu L, Liu X, Liu B. Complex network approach for investigating the herb-symptom correspondence phenomenon and analyzing the TCM clinical herb-symptom association knowledge. BMC Complement Altern Med 2014 (Accepted)
Zhou XZ, Zhang RS, Shah J, Rajgor D, Wang YH, Pietrobon R, Liu BY, Chen J, Zhu JG, Gao RL. Patterns of herbal combination for the treatment of insomnia commonly employed by highly experienced Chinese medicine physicians. Chin J Integr Med 2011; 17(9): 655–662
Mirnezami R, Nicholson J, Darzi A. Preparing for precision medicine. N Engl J Med 2012; 366(6): 489–491
O’Connor TG, McGuire S, Reiss D, Hetherington EM, Plomin R. Co-occurrence of depressive symptoms and antisocial behavior in adolescence: a common genetic liability. J Abnorm Psychol 1998; 107(1): 27–37
Zhou X, Peng Y, Liu B. Text mining for traditional Chinese medical knowledge discovery: a survey. J Biomed Inform 2010; 43(4): 650–660
Chen J, Lu P, Zuo X, Shi Q, Zhao H, Luo L, Yi J, Zheng C, Yang Y, Wang W. Clinical data mining of phenotypic network in angina pectoris of coronary heart disease. Evid Based Complement Alternat Med 2012; 2012: 546230
Zhao Y, Zhang NL, Wang T, Wang Q. Discovering symptom co-occurrence patterns from 604 cases of depressive patient data using latent tree models. J Altern Complement Med 2014; 20(4): 265–271
Liu B, Chen S, Zhou X, Ni Q, He L. The principle of patient classification for type 2 diabetes based on symptoms. Beijing J Tradit Chin Med (Beijing Zhong Yi) 2009; 28: 267–269 (in Chinese)
Yan S, Zhang R, Zhou X, Li P, He L, Liu B. Exploring effective core drug patterns in primary insomnia treatment with Chinese herbal medicine: study protocol for a randomized controlled trial. Trials 2013; 14(1): 61
Zhang L, Wang, J, Wang Y. Research on FANG-ZHENG Correspondence. China J Tradit Chin Med Pharm (Zhonghua Zhong Yi Yao Za Zhi) 2005; 20: 8–10 (in Chinese)
Zhang XP, Zhou XZ, Huang HK, Feng Q, Chen SB, Liu BY. Topic model for Chinese medicine diagnosis and prescription regularities analysis: case on diabetes. Chin J Integr Med 2011; 17(4): 307–313
Poon J, Luo Z, Zhang RS. Feature representation in the biclustering of symptom-herb relationship in Chinese medicine. Chin J Integr Med 2011; 17(9): 663–668
Liu GP, Li GZ, Wang YL, Wang YQ. Modelling of inquiry diagnosis for coronary heart disease in Traditional Chinese Medicine by using multi-label learning. BMC Complement Altern Med 2010; 10(1): 37
Zhou X, Liu B, Wu Z, Feng Y. Integrative mining of traditional Chinese medicine literature and MEDLINE for functional gene networks. Artif Intell Med 2007; 41(2): 87–104
Su SB, Jia W, Lu A, Li S. Evidence-Based ZHENG: A Traditional Chinese Medicine Syndrome 2013. Evid Based Complement Alternat Med 2014; 2014: 484201
Li S, Fan TP, Jia W, Lu A, Zhang W. Network pharmacology in traditional chinese medicine. Evid Based Complement Alternat Med 2014; 2014: 138460
Liu B, Zhou X, Wang Y, Hu J, He L, Zhang R, Chen S, Guo Y. Data processing and analysis in real-world traditional Chinese medicine clinical data: challenges and approaches. Stat Med 2012; 31(7): 653–660
Zhou X, Chen S, Liu B, Zhang R, Wang Y, Li P, Guo Y, Zhang H, Gao Z, Yan X. Development of traditional Chinese medicine clinical data warehouse for medical knowledge discovery and decision support. Artif Intell Med 2010; 48(2–3): 139–152
Liu B, Zhang Y, Hu J, He L, Zhou X. Thinking and practice of accelerating transformation of traditional Chinese medicine from experience medicine to evidence-based medicine. Front Med 2011; 5(2): 163–170
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Zhou, X., Li, Y., Peng, Y. et al. Clinical phenotype network: the underlying mechanism for personalized diagnosis and treatment of traditional Chinese medicine. Front. Med. 8, 337–346 (2014). https://doi.org/10.1007/s11684-014-0349-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11684-014-0349-8